The Application Notebook
When working with complex matrices such as personal care products, sample preparation is perhaps the most difficult step of the analysis process. By utilizing a targeted sample preparation technique, such as ion-exchange SPE, analysis can be significantly improved as compared to less targeted techniques such as liquid-liquid extraction.
When working with complex matrices such as personal care products, sample preparation is perhaps the most difficult step of the analysis process. By utilizing a targeted sample preparation technique, such as ion-exchange SPE, analysis can be significantly improved as compared to less targeted techniques such as liquid-liquid extraction. Our work successfully extracted metronidazole from foaming facial cleanser using a polymeric cation-exchange SPE sorbent, Strata™ -X-C, followed by a rapid LC–MS-MS analysis on a Kinetex® 2.6 µm XB-C18 HPLC/UHPLC core-shell column.
Sample Pretreatment:
1. Dissolve 0.250 g of Foaming Facial Cleanser in 10 mL of 0.1 N HCl
2. Vortex until homogeneous
3. Centrifuge sample at 5000g for 5 min
The pretreated sample is further cleaned up and concentrated using SPE.
Cartridge: Strata-X-C, 30 mg/3 mL
Condition: 1 mL methanol
Equilibrate: 1 mL 0.1 N HCl
Load: 3 mL of pretreated sample
Wash 1: 3 mL 0.1 N HCl
Wash 2: 3 mL methanol
Wash 3: 6 mL ethyl acetate
Dry: 5 min under full vacuum
Elute: 1 mL 5% NH4OH in methanol (v/v)
Dry down: Evaporate under a stream of nitrogen gas at 50 °C until dry
Reconstitute: Reconstitute samples with 200 µL of methanol/0.1% formic acid (10:90)
We were able to effectively extract metronidazole from foaming facial cleanser using a targeted SPE procedure on Strata-X-C polymeric SPE sorbent. The cation-exchange properties of the Strata-X-C SPE sorbent targeted the sp2 hybridized nitrogen at the 3 position of the imidazole ring in the metronidazole structure, forming a tight bond between the sorbent and the metronidazole compound. The strong interaction allowed a strong solvent wash of ethyl acetate to be performed which removed a significant amount of matrix interferences (Figure 1).
Figure 1: The vial on the left was not subjected to a strong organic wash and therefore contains matrix interferences such as foaming agents. After a strong ethyl acetate wash, matrix interferences are no longer present in the vial on the right.
By implementing a targeted SPE method, matrix interferences were significantly removed from a foaming facial cleanser matrix. This cleanup process allowed for a sensitive LC–MS-MS method that could detect metronidazole at low levels, down to 100 pg/mL. (Visit www.phenomenex.com/Application and search for Application No. 20631 for LC–MS-MS conditions).
Phenomenex Inc.
411 Madrid Avenue, Torrance, CA 90501
Tel. (310) 212-0555, (310) 328-7768
Website: www.phenomenex.com
Mitigating High Sample Volume Consumption in AAV Aggregate Analysis Using a Biozen™ dSEC-7 by SEC-FL
April 15th 2024This application note showcases a Biozen dSEC-7 SEC chemistry/fluorescence detector solution, offering reliable AAV aggregate analysis in under 10 minutes with as little as 0.5 µL of sample. Across four AAV serotypes, resolution between monomer and aggregates remains consistently high, emphasizing Biozen dSEC-7's efficiency and ability to maintain accurate detection at minimal injection volumes. Ideal for routine testing, this solution ensures precise measurement of a CQA with streamlined sample consumption.
Adeno-Associated Virus (AAV) Serotype Screen Using a Biozen™ dSEC-7 Size Exclusion Column
April 15th 2024With its 700 Å large pore silica particle and hydrophilic diol-type surface chemistry, Biozen dSEC-7 provides excellent resolution of monomer from dimer peaks in under 8 minutes across four different AAV serotypes. This capability is crucial for optimizing gene therapy biopharmaceuticals, ensuring thorough analytical scrutiny to select the most appropriate serotype(s) for enhanced therapeutic outcomes and immunogenic profiles.